Rare Cancers – more common than you think
ESMO Video Commentary:
Personalised medicine in head and neck cancers
More than 4.3 million people in the European Union are affected by rare cancers. Despite the rarity of each of the 198 rare cancers, they represent in total about 22% of all cancer cases, including all cancers in children, diagnosed in the EU28 each year.
Rare Cancers Europe (RCE) is a multi-stakeholder initiative dedicated to putting rare cancers firmly on the European policy agenda and to implementing 39 political and stakeholder recommendations.
21 Mar 2017
ESMO Open - Male breast cancer: finding the way in this uncommon path
Knowledge of this disease is limited and mainly derives from small single-institution retrospective studies with contradictory results.
09 Mar 2017
Video: European Reference Networks for rare and complex diseases
Joining up of EU's best expertise on this scale should benefit every year thousands of patients
24 Feb 2017
Study reveals PGK1 enzyme as therapeutic target for deadliest brain cancer
Discovery of a dual role played by the enzyme phosphoglycerate kinase 1 (PGK1) may indicate a new therapeutic target for glioblastoma